Evaluation of citrate consumption by microorganisms in anticoagulant bags of sodium citrate in case of contamination

Document Type : Original Article

Authors

1 No. 241, Ninth East Golestan St., Baharestan Industrial Town, 5 km of Karaj-Qazvin Highway

2 No. 241, Ninth East Golestan St., Baharestan Industrial Town, km 5 of Karaj-Qazvin Highway

10.22034/mbt.2021.298668.1003

Abstract

Stability in the amount of sodium citrate in anticoagulant bags is very important. Ensuring that this substance is not reduced or degraded in all manufacturing processes up to storage is a requirement of pharmaceutical companies producing anticoagulants containing sodium citrate. Many citrate-consuming microorganisms can reduce the amount of sodium citrate present in the product, which doubles the importance of checking for the absence of these microorganisms before final sterilization. In the present study, Sodium citrate 4% (w/v) bags were inoculated with half McFarland suspension of 4 bacterial strains Pseudomonas aeruginosa, Serratia marcescens, Klebsiella Pneumoniae, Enterococcus Faecalis separately and incubated at 35 ° C for 120 hours until citrate was consumed. Citrate levels were measured at the pre-inoculation stage and then up to 120 hours at regular intervals. The results showed that the amount of citrate remaining in the sample inoculated with K. Pneumoniae was significantly (p< 0.05) the lowest and in the samples inoculated with P. aeruginosa and E. Faecalis was significantly (p< 0.05) the highest.

Keywords


  • Jaffé ER, Kaushansky K, The American Society of Hematology: a success at age 50. Blood, The Journal of the American Society of Hematology, 2008, 111(1):11-5, DOI: 1182/blood-2007-09-112326.
  • Greening DW, Glenister KM, Sparrow RL, Simpson RJ. International blood collection and storage: clinical use of blood products. Journal of proteomics, 2010 Jan 3;73(3):386-95, DOI: 1016/j.jprot.2009.07.011.
  • Yuan F, Li Z, Li X, Liu H. Application of regional citrate anticoagulation in membrane therapeutic plasma exchange. International Urology and Nephrology, 2020 Dec; 52(12):2379-84, DOI: 1007/s11255-020-02581-0.
  • del Castillo J, López-Herce J, Cidoncha E, Urbano J, Mencía S, Santiago MJ, Bellón JM. Circuit life span in critically ill children on continuous renal replacement treatment: a prospective observational evaluation study. Critical Care. 2008 Aug; 12(4):1-8, DOI:1186/cc6965.
  • Zhang Z, Hongying N. Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy. Intensive care medicine. 2012 Jan; 38(1):20-8, DOI:1007/s00134-011-2438-3.
  • Van de Wetering J, Westendorp RG, Van der Hoeven JG, Stolk B, Feuth JD, Chang PC. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. journal of the American society of nephrology, 1996 Jan 1;7(1):145-50, DOI: 1681/ASN.V71145.
  • Cerón JJ, Martı́nez-Subiela S, Hennemann C, Tecles F, The effects of different anticoagulants on routine canine plasma biochemistry, The Veterinary Journal. 2004 May 1;167(3):294-301, DOI: 1016/j.tvjl.2003.09.009.
  • Anitua E, Zalduendo M, Troya M, Alkhraisat MH. The influence of sodium citrate on the characteristics and biological activity of plasma rich in growth factors. Regenerative Medicine. 2020 Oct;15(10):2181-92, DOI:2217/rme-2020-0082
  • Grudzinski L, Quinan P, Kwok S, Pierratos A. Sodium citrate 4% locking solution for central venous dialysis catheters—an effective, more cost-efficient alternative to heparin. Nephrology Dialysis Transplantation. 2007 Feb 1;22(2):471-6, DOI: 1093/ndt/gfl606
  • Mollison PL. The introduction of citrate as an anticoagulant for transfusion and of glucose as a red cell preservative. British journal of haematology. 2000;108(1):13-8, DOI: 10.1046/j.1365-2141.2000.01827.x.
  • Johnson M, Hillier K. Sodium Citrate , 2011, DOI: 10.1016/B978-008055232-3.62638-8
  • Bowen RA, Hortin GL, Csako G, Otañez OH, Remaley AT. Impact of blood collection devices on clinical chemistry assays. Clinical biochemistry. 2010 Jan 1;43(1-2): 4-25, DOI: 1016/j.clinbiochem.2009.10.001.
  • Antranikian G, Giffhorn F. Citrate metabolism in anaerobic bacteria. FEMS Microbiology Reviews. 1987 Jun 1;3(2):175-98, DOI: 10.1016/0378-1097(87)90063-2
  • Hurst CJ, Crawford RL, Garland JL, Lipson DA, Manual of environmental microbiology. American Society for Microbiology Press; 2007 May 14.
  • Sutton S. Measurement of cell concentration in suspension by optical density. microbiology. 2006; 585: 210-8336.
  • Bott M. Anaerobic citrate metabolism and its regulation in enterobacteria, Archives of microbiology. 1997 Mar;167(2):78-88, PMID: 9133329.
  • Adeolu M, Alnajar S, Naushad S, Gupta RS. Genome-based phylogeny and taxonomy of the ‘Enterobacteriales’: proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov. International journal of systematic and evolutionary microbiology. 2016 Dec 1;66(12):5575-99,  DOI: 1099/ijsem.0.001485.
  • Pendleton JN, Gorman SP, Gilmore BF. Clinical relevance of the ESKAPE pathogens. Expert review of anti-infective therapy. 2013 Mar 1;11(3):297-308, DOI: 1586/eri.13.12.
  • Chen YT, Liao TL, Wu KM, Lauderdale TL, Yan JJ, Huang IW, Lu MC, Lai YC, Liu YM, Shu HY, Wang JT. Genomic diversity of citrate fermentation in Klebsiella pneumoniae. BMC microbiology. 2009 Dec;9(1):1-9. DOI: 1186/1471-2180-9-168.
  • D’Angelo M, Martino GP, Blancato VS, Espariz M, Hartke A, Sauvageot N, Benachour A, Alarcón SH, Magni C. Diversity of volatile organic compound production from leucine and citrate in Enterococcus faecium, Applied microbiology and biotechnology, 2020 Feb;104(3):1175-86, DOI: 1007/s00253-019-10277-4.
  • Hugenholtz J, Perdon L, Abee T. Growth and energy generation by Lactococcus lactis subsp, lactis biovar diacetylactis during citrate metabolism. Applied and Environmental Microbiology, 1993 Dec;59(12):4216-22, DOI: 1128/aem.59.12.4216-4222.1993.
  • Kennes C, Dubourguler HC, Albagnac G, Nyns EJ. Citrate metabolism by Lactobacillus plantarum isolated from orange juice. Journal of applied bacteriology. 1991 May;70(5):380-4, DOI: 1007/BF00172728.
  • Sarantinopoulos P, Kalantzopoulos G, Tsakalidou E. Citrate metabolism by Enterococcus faecalis FAIR-E 229. Applied and Environmental Microbiology. 2001 Dec 1;67(12):5482-7,  DOI: 1128/AEM.67.12.5482-5487.2001.
  • Behzadi P, Baráth Z, Gajdács M. It’s not easy being green: A narrative review on the microbiology, virulence and therapeutic prospects of multidrug-resistant Pseudomonas aeruginosa. Antibiotics. 2021 Jan;10(1):42, DOI: 3390/antibiotics10010042.
  • Long SS, Prober CG, Fischer M. Principles and practice of pediatric infectious diseases E-Book. Elsevier Health Sciences; 2017 May 9.
  • Mollison PL. The introduction of citrate as an anticoagulant for transfusion and of glucose as a red cell preservative. British journal of haematology. 2000;108(1):13-8, DOI: 1046/j.1365-2141.2000.01827.x
  • Lee DH, Koh EH, Choi SR, Kim S, Kim DH, Lee NY. Effect of sodium citrate on growth of bacteria in blood culture. Annals of Clinical Microbiology. 2013 Dec 1;16(4):168-73, DOI: 5145/ACM.2013.16.4.168.
  • De Vos J, Hombrouckx R. Citrate anticoagulation and adverse events. EDTNA/ERCA journal (English ed.). 2003 Jul 1;29(3):112-3, DOI: 1111/j.1755-6686.2003.tb00289.x.
  • Fernández SN, Santiago MJ, López-Herce J, García M, Del Castillo J, Alcaraz AJ, Bellón JM. Citrate anticoagulation for CRRT in children: comparison with heparin. BioMed research international. 2014 Aug 3;2014, DOI: 1155/2014/786301.
  • Anitua E, Zalduendo M, Troya M, Alkhraisat MH. The influence of sodium citrate on the characteristics and biological activity of plasma rich in growth factors. Regenerative Medicine. 2020 Oct;15(10):2181-92, DOI: 2217/rme-2020-0082.